May 17, 2022, 15:42 PM by

May 17, 2022, 15:42 PM by

May 17, 2022, 01:00 AM by User Not Found

Bio-IT World | Bio-IT World Conference & Expo panelists discussed how diversity, equity, and inclusion are critical to the efficacy of precision medicine. Moderator Kevin Ileka, Bristol Myers Squibb Co., was joined by Adrian Coles, Bristol Myers Squibb Co.; Ari Berman, BioTeam Inc; Lori Lennon, Thinkubator Media; and Victoria Parker, NOBCChE.

May 13, 2022, 01:00 AM by User Not Found

Bio-IT World | Chris Dagdigian wasn’t the only one reporting from the IT trenches last week. The Bio-IT World Conference & Expo’s annual Trends from the Trenches panel also featured three other BioTeam consultants: Adam Kraut, Michelle Bayly, and Anna Sowa. The three reported on their own observations in their capacities as BioTeam consultants: focusing on leadership trends, platform best practices, and AI.

May 12, 2022, 01:00 AM by User Not Found

Bio-IT World | At Bio-IT World’s 20th anniversary event last week, Chris Dagdigian and friends from BioTeam, once again closed out programming with a rapid-fire look at the bio-IT landscape and an IT trends assessment—calling out what is working, what’s not, and how it’s all evolving.

May 11, 2022, 01:00 AM by User Not Found

Bio-IT World | A pioneering program of Geisinger Health System has returned clinically actionable results from exome sequencing to a record-breaking 3,400 individuals at increased risk for potentially life-threatening conditions such as hereditary breast and colon cancers, familial hypercholesterolemia (FH), and heart disease. The MyCode Community Health Initiative, enabled by a 2014 agreement with Regeneron Pharmaceuticals, draws from participants in a sizable DNA biobank who agree to the sequencing and results reporting.

May 9, 2022, 01:00 AM by User Not Found

Bio-IT World | The advancement of next generation sequencing (NGS) technologies has represented a large step forward in the speed and throughput of sequencing capabilities and make it more affordable to sequence an entire genome. While NGS has dramatically lowered the cost of sequencing a sample, it can still be relatively costly to sequence an entire genome if you are only interested in a small portion of it. For these situations, target enrichment can be used to selectively sequence regions of interest.

May 5, 2022, 00:00 AM by User Not Found

Bio-IT World | Bio-IT World announced Best of Show awards yesterday evening at the Bio-IT World Conference and Expo. The new products awards program, which has not been held since 2019, recognizes innovative solutions to important problems facing the life sciences industry. The judges named six award winners and the Bio-IT World community chose a People’s Choice Award.

May 4, 2022, 00:00 AM by User Not Found

Bio-IT World | George Church opened the 20th Anniversary Bio-IT World Conference & Expo last night, speaking virtually to a packed room at Boston’s Hynes Convention Center while many more attendees tuned in online.

May 3, 2022, 01:00 AM by User Not Found

Bio-IT World | Bio-IT World is pleased to announce the competitors in the 2022 Best of Show competition with the Bio-IT World People’s Choice Award. Voting begins today.

Apr 29, 2022, 01:00 AM by User Not Found

Bio-IT World | Funding for programmable biology and chemistry in medicine development, DNA synthesis, immune-oncology cancer therapeutics, and more.

Apr 28, 2022, 01:00 AM by User Not Found

Bio-IT World | AI and ML in clinical trials, metabolomics-based diagnostics, T-cell receptor engineering for cancer treatment, and cardiovascular disease drug development, new genomics efforts in Brazil, laboratory automation and risk management solutions, and more.

Apr 26, 2022, 01:00 AM by User Not Found

Bio-IT World | James Cuff summarizes his career over the past 25 years or so, outlining where he’s seen updates in the space and which things have fundamentally stayed the same. He also shares about the problem that’s been bugging him for the past five years and the new company he’s joined that could fix it.

Apr 25, 2022, 17:19 PM by

Vyasa, an innovative provider of highly scalable deep learning AI analytics software for healthcare, life sciences, and business applications, announced today the availability of its Vyasa Layar offering on SAP® Store, the online marketplace for SAP and partner offerings. Through Vyasa Layar data fabric, users can connect to Sybase® and to SAP Business Technology Platform (SAP BTP) with SAP HANA® to create a unified data experience regardless of data format or storage location.

Apr 25, 2022, 17:19 PM by

Global pharmaceutical contract packaging organisation (CPO), Tjoapack has announced the completion of its expansion plans following a €10m+ plus investment at its Etten-Leur facility in the Netherlands.

Apr 25, 2022, 17:19 PM by

Rho Appoints Peter Schmidt, Ph.D., as SVP, Government Partnerships, Executive Committee Member Former Vice Dean at East Carolina University’s Brody School of Medicine brings scientific and strategic expertise to lead the federally funded clinical research enterprise of this international CRO. Research Triangle Park, NC – April 19, 2022 – Rho, a global full-service contract research organization (CRO) with a proven track record of drug development success, has appointed Peter Schmidt, Ph.D., as Senior Vice President, Government Partnerships of Rho’s Federal Systems Division. For over 30 years, Rho has worked closely with NIH/NIAID and other federal departments on groundbreaking clinical trial and epidemiologic studies, including the LEAP peanut allergy study. “I am thrilled to welcome Dr. Schmidt to Rho," said Dr. Laura Helms Reece, CEO, Rho. “He is a preeminent neuroscientist and recognized leader across federal, commercial and academic arenas. His expertise in clinical research is remarkable, and his command of central nervous system, infectious disease, and other indications is a great fit with Rho’s focus in those areas. I am eager to work with Dr. Schmidt as he brings exciting strategic and scientific leadership to our federal business. His experience and judgment will be great additions to our Executive Committee.”

Apr 25, 2022, 17:19 PM by

Recipharm, a leading global contract development and manufacturing organisation (CDMO), today announces the closing of its acquisitions of advanced therapy CDMO Arranta Bio and virotherapy CDMO Vibalogics.

Apr 25, 2022, 17:19 PM by

Apr 25, 2022, 17:19 PM by

Huateng Pharma is a full-service Contract Development Manufacturing Organizations (CDMO) for pharmaceutical intermediates, including paxlovid and ensitrelvir intermediates.

Apr 25, 2022, 17:19 PM by

Medi-Tech Insights offers an interesting research report on Global Single-Cell Analysis Market. The market growth is likely to be driven by emerging life science and oncology research.